The Diagnostic Imaging mammography modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of mammography, including 2D digital mammography, digital breast tomosynthesis, and breast ultrasound.
October 17th 2025
Concordant mammography detection of breast cancer by radiologists and AI had over a threefold higher likelihood of future incidental breast cancer in comparison to positive radiologist assessment and negative AI evaluation, according to new research involving over 82,000 women.
Can AI Improve the Consistency of Breast Density Assessment by Radiologists?
December 6th 2022In a recent video interview, Susan Holley, MD discussed key findings from a large retrospective longitudinal study, presented at the recent Radiological Society of North America (RSNA) conference, which found that an emerging artificial intelligence (AI) model was over 24 percent more consistent than radiologist assessment of breast density.
AI Assessment of 3D Digital Breast Tomosynthesis Images May Help Predict Breast Cancer
November 30th 2022An emerging artificial intelligence algorithm, developed to estimate volumetric breast density from 3D-reconstructed digital breast tomosynthesis images, could potentially facilitate individual risk assessments for breast cancer.
Current Insights on AI, Breast Cancer Screening and the FDA
November 8th 2022In a recently published article, researchers from Yale University discuss the pros and cons of current FDA regulations as they apply to the clearance and use of adjunctive artificial intelligence (AI) software with conventional breast cancer screening modalities such as mammography.
Can AI-Powered Virtual Biopsies Improve Detection of Breast Lesion Subtypes on Digital Mammography?
October 27th 2022In separate test sets of Israeli women and United States women who had either ductal carcinoma in situ or invasive breast cancer, emerging artificial intelligence (AI) algorithms achieved an area under the curve (AOC) of 88 percent and 80 percent, respectively, for malignancy detection.
Key Considerations with Implementing Contrast-Enhanced Mammography in Your Practice
October 12th 2022As literature continues to emerge about the potential of contrast-enhanced digital mammography (CEDM), this author reviews clinical and practical benefits of the modality and pertinent steps for adding it to your diagnostic armamentarium.
Digital Breast Tomosynthesis and Breast Density: What a New Study Reveals
October 6th 2022In a large study of nearly 100,000 women, researchers found that the combination of digital breast tomosynthesis (DBT) and synthesized mammography had more than triple the detection rate for invasive breast cancer in extremely dense breasts in comparison to digital mammography alone.
Study Finds No Benefit to MRI Screening in Women with High-Risk Breast Lesions
October 3rd 2022In a study involving nearly 700 patients with atypical ductal or lobular hyperplasia, or lobular carcinoma in situ, researchers found no difference in four-year breast cancer detection rates between women who had screening mammography and breast magnetic resonance imaging (MRI), and women who only had mammography screening.
What a New Meta-Analysis Reveals About Breast Density, Mammography and MRI Screening
September 28th 2022Assessing data from 386,590 women, researchers noted that women with extremely dense breast tissue have more than double the risk for breast cancer in comparison to women with average breast density and nearly four times the risk of women with extremely fatty breast tissue.
New Mammography Study Examines Association Between Breast Density Changes and Breast Cancer Risk
September 22nd 2022In a retrospective review involving over 2.2 million women with three consecutive biennial mammography screenings and no history of breast cancer, researchers noted that for premenopausal women with fatty breasts at baseline, increasing breast density at subsequent screenings led to significantly elevated hazard ratios ranging from 1.45 to 1.93 for the risk of breast cancer.